Shanchol vaccine

BIOLOGICAL2 trials

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh, Bharat Biotech International Limited

Conditions

Cholera

Phase 3

A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).

Bharat Biotech International LimitedCholera

Start: 2022-02-22End: 2022-10-30Updated: 2022-08-18

Unknown Phase

Oral Cholera Vaccine Delivery in Rural Bangladesh

CompletedNCT01811771

International Centre for Diarrhoeal Disease Research, BangladeshCholera

Start: 2012-08-31End: 2015-08-31Updated: 2015-10-14